Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders.
about
A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infectionRecent advances in the diagnosis of antiphospholipid syndrome.The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus.Demonstration of antiphospholipid antibody heterogeneity by phospholipid column chromatography and salt gradient elution techniques.Origin and pathogenesis of antiphospholipid antibodies.Laboratory techniques in the diagnosis of syphilis: a review.Antiphospholipid syndrome: an overview.HIV-1: maternal prognosis.Anticardiolipin and anti-beta-2-glycoprotein I antibodies.Fatty acids of Treponema pallidum and Borrelia burgdorferi lipoproteins.Laboratory diagnosis and management challenges in the antiphospholipid syndrome.Diagnosis of antiphospholipid syndrome.Serologic tests for syphilis.Differences in functional activity of anticardiolipin antibodies from patients with syphilis and those with antiphospholipid syndromeThe antiphospholipid syndrome. Diagnosis, management, and pathogenesis.Cryptic antiphospholipid autoantibodies and serum co-inhibitors.Beta 2-glycoprotein I.Anticardiolipin antibodies: specificity and function.Infective endocarditis, rheumatoid factor, and anticardiolipin antibodies.Beta 2-glycoprotein 1 (beta 2GP1) enhances cardiolipin binding activity but is not the antigen for antiphospholipid antibodies.Immunoglobulin class and subclass restriction of autoimmune responses in secondary syphilis.Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo.Antiphospholipid antibodies--new insights into their specificity and clinical importance.Heterogeneity of binding reactivity to different phospholipids of antibodies from patients with systemic lupus erythematosus (SLE) and with syphilis.Antibodies against platelet-activating factor in patients with antiphospholipid antibodies.Treponemal phospholipids inhibit innate immune responses induced by pathogen-associated molecular patterns.Intrauterine fetal death in mice caused by cytomegalovirus-derived peptide induced aPL antibodies.The role of antiphospholipid antibodies (aPls) in infertile women: the long-lasting experience.Role of beta 2-glycoprotein I in the anticardiolipin antibody affinity for phospholipid in autoimmune disease.Antiphospholipid antibodies, beta 2-glycoprotein I and thrombosis.
P2860
Q28207774-6D3581F3-47CD-4428-BC46-5F2123077F01Q33345276-096BD7AB-55D0-4CC1-A6E9-1A4969E1C39CQ33360375-C5CB5FC8-A2AF-4C5A-BB55-212E31A77B3AQ33495018-6702E82B-E5C1-4DE0-85A7-DBE1801BD458Q33503275-54EFF65B-EE11-4E3F-8E14-90C0135D9011Q33934142-81B6C905-1022-40EF-82E0-B4BFB353F9FBQ35099505-1B84600E-D229-488D-9FB6-00C0D21C83F5Q35695524-0D320DFB-7465-4958-8B20-6F5B1F7F0CFCQ36086136-2F854D2D-5CAD-40DD-A06E-ADE2492E2AF9Q36106623-48D678DB-0587-4F89-8153-284813CBEF7AQ36458164-51D9E6DE-99AC-47A5-B256-37F42496968AQ36577371-E9EE3BD9-32FD-4079-84CA-AC984B6EECBBQ38143273-9F3FC7F8-1D0E-45F3-8894-0C64CA893ABCQ40375413-362D01D5-1BA9-4FBD-B30B-F9F5E05C6A0FQ40467260-97DD6447-2FB2-476A-863D-F4B80943D3F6Q40540320-B630C46A-CBC3-4725-A787-70B9A89682A3Q40558449-9EA15332-723F-4FE9-957E-268F088B9E21Q40558462-C0918420-0EE2-4539-AE61-E8157A776DF0Q41217831-0D0D2564-BB95-4D87-9FEA-354DF5B5313CQ43464737-06C57328-97CA-4F20-A90C-14ACB0C74A3DQ43829900-52D4C783-42B7-4869-A47F-2FAFDA2201C1Q43882937-A6878C3E-B60C-43D0-B1FD-8AD313F19A8DQ43931131-B3ADE0F6-4A24-4BD8-85CE-6605929C128AQ44440961-47B98319-1872-45DE-9639-008723A747D4Q44557656-5E9F023E-39C0-4B4A-B6F3-5653567469EFQ44567851-98F7A5AE-23E3-40D2-AB05-1DC4FA75FECBQ45077755-61E05CB2-54E9-46A3-B7DA-81C35896A71CQ47416196-10211791-E6C1-4EFC-A454-52CA53C42873Q48030191-13CB6D65-7EEA-48A1-89F6-62977BABF3C0Q53979828-7E3C3597-3D89-406A-BEC6-41F96C058E5C
P2860
Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders.
description
1988 nî lūn-bûn
@nan
1988 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Use of an enzyme-linked immuno ...... hilis or autoimmune disorders.
@ast
Use of an enzyme-linked immuno ...... hilis or autoimmune disorders.
@en
type
label
Use of an enzyme-linked immuno ...... hilis or autoimmune disorders.
@ast
Use of an enzyme-linked immuno ...... hilis or autoimmune disorders.
@en
prefLabel
Use of an enzyme-linked immuno ...... hilis or autoimmune disorders.
@ast
Use of an enzyme-linked immuno ...... hilis or autoimmune disorders.
@en
P50
P356
P1476
Use of an enzyme-linked immuno ...... hilis or autoimmune disorders.
@en
P2093
P356
10.1093/INFDIS/157.1.23
P407
P577
1988-01-01T00:00:00Z